Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹3,925 Cr₹2,435 Cr₹2,387 Cr₹5,016 Cr₹3,329 Cr

What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA is ₹3,925 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹3,925 Cr
Mar2024₹2,435 Cr
Mar2023₹2,387 Cr
Mar2022₹5,016 Cr
Mar2021₹3,329 Cr

How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹3,925 Cr
61.21
Mar2024 ₹2,435 Cr
2.00
Mar2023 ₹2,387 Cr
-52.42
Mar2022 ₹5,016 Cr
50.69
Mar2021 ₹3,329 Cr -

Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,090.9 Cr -0.7% 3.9% -6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,631.0 Cr 1.9% -0.8% -3.5% Stock Analytics
DIVIS LABORATORIES ₹175,111.0 Cr 3.2% 4.8% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,228.0 Cr 6.3% 8.9% 15.8% Stock Analytics
CIPLA ₹117,983.0 Cr -3.3% -2% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,782.0 Cr -3.8% -3.1% -8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.7%

3.9%

-6%

SENSEX

-1.2%

-1.1%

6.3%


You may also like the below Video Courses